comparemela.com

Latest Breaking News On - Guardant health stock performance - Page 3 : comparemela.com

Analysts Set Guardant Health, Inc (NASDAQ:GH) Target Price at $55 44

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in […]

Guardant Health (NASDAQ:GH) Stock Rating Reaffirmed by Citigroup

Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “buy” rating reissued by Citigroup in a research note issued on Monday, Benzinga reports. They currently have a $50.00 target price on the stock. Citigroup’s price target would suggest a potential upside of 72.24% from the company’s current price. Several other equities research analysts have […]

SWS Partners Boosts Position in Guardant Health, Inc (NASDAQ:GH)

SWS Partners raised its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 8.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,492 shares of the company’s stock after buying an additional 3,391 shares during the period. SWS Partners’ […]

Guardant Health (NASDAQ:GH) Given New $55 00 Price Target at Morgan Stanley

Guardant Health (NASDAQ:GH – Get Free Report) had its price objective cut by equities researchers at Morgan Stanley from $60.00 to $55.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.